These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12675892)

  • 1. Infection rates of the LifeSite hemodialysis access system.
    Ross JJ; Narayan G
    Kidney Int; 2003 May; 63(5):1963; author reply 1963. PubMed ID: 12675892
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicenter clinical trial results with the LifeSite hemodialysis access system.
    Schwab SJ; Weiss MA; Rushton F; Ross JP; Jackson J; Kapoian T; Yegge J; Rosenblatt M; Reese WJ; Soundararajan R; Work J; Ross J; Stainken B; Pedan A; Moran JA
    Kidney Int; 2002 Sep; 62(3):1026-33. PubMed ID: 12164887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety results with the LifeSite hemodialysis access system versus the Tesio-Cath hemodialysis catheter at 12 months.
    Rosenblatt M; Caridi JG; Hakki FZ; Jackson J; Kapoian T; Martin SP; Moran J; Pedan A; Reese WJ; Ross JP; Ross J; Rushton F; Schwab SJ; Soundararajan R; Stainken B; Weiss MA; Work J; Yegge J
    J Vasc Interv Radiol; 2006 Mar; 17(3):497-504. PubMed ID: 16567674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LifeSite Hemodialysis Access System in patients with limited access.
    Rayan SS; Terramani TT; Weiss VJ; Chaikof EL
    J Vasc Surg; 2003 Oct; 38(4):714-8. PubMed ID: 14560219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial clinical results with the LifeSite Hemodialysis Access System.
    Beathard GA; Posen GA
    Kidney Int; 2000 Nov; 58(5):2221-7. PubMed ID: 11044245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of LifeSite port systems for hemodialysis in Germany.
    Hollenbeck M; Zolotov D; Debusmann ER; Koch M; Wozniak G
    Clin Nephrol; 2005 Aug; 64(2):138-43. PubMed ID: 16114790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections associated with use of the LifeSite Hemodialysis Access System.
    Ross JJ; Narayan G; Bergeron EK; Worthington MG; Strom JA
    Clin Infect Dis; 2002 Jul; 35(1):93-5. PubMed ID: 12060883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilms and infection in dialysis patients.
    Dasgupta MK
    Semin Dial; 2002; 15(5):338-46. PubMed ID: 12358638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of a LifeSite Hemodialysis Access System pocket infection with large-volume kanamycin solution irrigation.
    Ross JR
    Adv Ren Replace Ther; 2003 Jul; 10(3):248-53. PubMed ID: 14708081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice guidelines for vascular access. Canadian Society pf Nephrology.
    Ethier JH; Lindsay RM; Barre PE; Kappel JE; Carlisle EJ; Common A
    J Am Soc Nephrol; 1999 Jun; 10 Suppl 13():S297-305. PubMed ID: 10425613
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long term experience with the LifeSite hemodialysis device].
    Virot JS; Nefti H; Heyani A; Janin G
    Nephrologie; 2003; 24(8):443-9. PubMed ID: 14737977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in patients with end-stage renal disease. An overview.
    Berman SJ
    Infect Dis Clin North Am; 2001 Sep; 15(3):709-20, vii. PubMed ID: 11570137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin catheter lock as a cause of gross overestimation of vancomycin pre-dialysis trough levels.
    Halleux D; Labriola L; Jadoul M
    Nephrol Dial Transplant; 2011 Jun; 26(6):2061-2; author reply 2062-3. PubMed ID: 21436377
    [No Abstract]   [Full Text] [Related]  

  • 14. Modified exchange technique for management of dysfunctional tunneled hemodialysis catheters in the presence of exit-site infection: a quality improvement report.
    Lai CH; Kan CD; Wu HY; Luo CY; Chao CM; Wen JS
    Am J Kidney Dis; 2009 Jan; 53(1):112-20. PubMed ID: 18976847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial colonization in a hemodialysis dual lumen temporary catheter].
    Moysés Neto M; Vieira-Neto OM; Figueiredo JF
    Rev Soc Bras Med Trop; 2003; 36(3):431-2. PubMed ID: 12908050
    [No Abstract]   [Full Text] [Related]  

  • 16. The LifeSite hemodialysis access system: implications for the nephrology nurse.
    Haynes BJ; Quarles AW; Vavrinchik J; White J; Pedan A
    Nephrol Nurs J; 2002 Feb; 29(1):27-33, 72. PubMed ID: 11887487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular and cardiac infections in end-stage renal disease.
    Manian FA
    Am J Med Sci; 2003 Apr; 325(4):243-50. PubMed ID: 12695730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leclercia adecarboxylata, an unusual hemodialysis catheter-related infection.
    Marina VP; Abidi S; Malhotra D
    Int Urol Nephrol; 2011 Dec; 43(4):1257-8. PubMed ID: 21626134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some aspects of infectious complications during chronic hemodialysis].
    Sukhodol'skaia AE; Terekhov NT; Mel'man NIa; Grechinskaia DA; Lukomskaia IG
    Urol Nefrol (Mosk); 1975; (4):36-9. PubMed ID: 1220115
    [No Abstract]   [Full Text] [Related]  

  • 20. Infectious spondylodiscitis in hemodialysis.
    García-García P; Rivero A; del Castillo N; Jarque A; Getino MA; García-Pérez J; Navarro-González JF
    Semin Dial; 2010; 23(6):619-26. PubMed ID: 21166877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.